Recent Developments in Pickering Emulsions for Biomedical Applications Clarissa L. G. Harman,a,b Mehzabin A. Patel,b Stefan Guldin,b Gemma-Louise Daviesa* a Department of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, UK b Department of Chemical Engineering, University College London, Torrington Place, London WC1E 7JE, UK. *Email:
[email protected] Keywords: Pickering emulsions, biomedicine, stimuli-responsive, therapeutic delivery Abstract Pickering emulsions, stabilised by organic or inorganic particles, offer long-term dispersibility of liquid droplets and resistance to coalescence. The versatility of stabilising particles and their ability to encapsulate and release cargo with high internal payload capacity makes them attractive in a wide variety of applications, ranging from catalysis to the cosmetic and food industry. While these properties make them an equally promising material platform for pharmaceutical and clinical applications, the development of Pickering emulsions for healthcare is still in its infancy. Herein, we summarise and discuss recent progress in the development of Pickering emulsions for biomedical applications, probing their design for passive diffusion-based release as well as stimuli-responsive destabilisation. We further comment on challenges and future directions of this exciting and rapidly expanding area of research. 1. Introduction Emulsion-based systems have been applied for several decades in a wide variety of fields, from drug delivery and pharmaceutics to cosmetics and the food industry, thanks to their relative ease of formulation for poorly soluble drugs and other substances. Pickering emulsions, first described in the early 1900s,[1,2] are stabilised by solid particles rather than surfactants and can offer a plethora of advantages over traditional emulsions, including increased stability against solvent coalescence, lower toxicity, and added functionality, derived from the properties of the stabilising particles themselves.